Witruth Capital is a financial service firm focusing on Chinese primary capital market and investment banking business for more than 8 years. The company has raised around 450 million for its customers through various types of financial transactions .So far, their team hold on to the spirit of ‘Global reach, China depth’, and they take ‘Support scientists and entrepreneurs for great achievements’ as their responsibility. Their members have accumulated decades of experience in areas of corporate finance and investment. Their fundamental focus is outstanding enterprises in TMT and bio-pharmaceutical divisions, and they are dedicated to helping and directing them to success.Witruth Capital currently has 3 subsidiary brands: Century Finance (focused on investment banking and financial advisory business), Witruth Capital (focused on private equity investment business) and Wootou.com (financial technology). There are 2 equity investment funds in existence so far. Zhicheng Daohe focuses on mid-early stage VC investment with transaction size around 5 million, and Zhicheng Huiyuan on later stage PE opportunities.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Feb 2, 2022
Singlomics
|
Series B | ¥300M | Biotechnology | — |
Apr 25, 2018
Innovative Cellular Therapeutics
|
Series B | $28.60M | Biotechnology | — |
Jul 8, 2016
Helowin
|
Series E | ¥50M | Big Data | — |